A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety — Stella

Home/Epileptic Encephalopathy/

View on ClinicalTrials.gov

Recruiting

Back to Epileptic Encephalopathy trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

United States

Praxis Research Site, San Diego, California

Praxis Research Site, Chicago, Illinois

Key details

Phase

Large-scale testing

Sponsor

Praxis Precision Medicines

Enrollment target

~50 participants

Started

August 2025

Primary completion

June 2026

Age range

1 Day – 18 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.